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ABSTRACT 
The best-studied amidase signature (AS) enzyme is probably fatty acid amide hydrolase 
(FAAH). Closely related to FAAH is mandelamide hydrolase (MAH), whose substrate 
specificity and mechanism of catalysis are described in this paper. First, we developed a 
convenient chromogenic substrate, 4-nitrophenylacetamide, for MAH. The lack of reactivity of 
MAH with the corresponding ethyl ester confirmed the very limited size of the MAH leaving 
group site. The reactivity of MAH with 4-nitrophenyl acetate and methyl 4-nitrophenyl 
carbonate, therefore, suggested formation of an “inverse” acyl-enzyme where the small acyl-
group occupies the normal leaving group site. We have interpreted the specificity of MAH for 
phenylacetamide substrates and small leaving groups in terms of its active site structure, using a 
homology model based on a FAAH crystal structure. The relevant structural elements were 
compared with those of FAAH. Phenylmethylboronic acid is a potent inhibitor of MAH (Ki = 27 
nM), presumably because it forms a transition state analogue structure with the enzyme. O-Acyl 
hydroxamates were not irreversible inactivators of MAH but some were found to be transient 
inhibitors. 
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1. Introduction 
 
Mandelamide hydrolase from Pseudomonas putida (MAH, EC 3.5.1.86) catalyzes the 
hydrolysis of mandelamide to mandelate and ammonia. MAH appears to be associated with the 
mandelate metabolic pathway of Pseudomonas putida, a pathway that allows this organism to 
utilize either of the enantiomers of mandelate as the sole carbon source. The gene encoding 
MAH, located within the gene cluster of the mandelate pathway enzymes of Pseudomonas 
putida ATCC 12633, has been identified and cloned [1]. MAH belongs to a large group of 
enzymes termed the amidase signature (AS) family. The AS enzymes share a highly conserved 
serine- and glycine rich stretch of amino acid sequence of approximately 50 amino acids. 
Proteins with AS sequences have been found from a wide range of organisms including archaea, 
eubacteria, fungi, nematodes, plants, insects, birds and mammals, where they perform diverse 
biological functions [2,3]. 
The AS enzymes are different from the large group of serine hydrolases that utilize a 
catalytic triad of Ser-His-Asp for hydrolysis of amides or esters, and possess a unique, highly 
conserved Ser-Ser-Lys catalytic triad [2,3]. The mammalian enzyme fatty acid amide hydrolase 
(FAAH) represents one of the best characterized AS enzymes. A catalytic mechanism for FAAH 
has been proposed based on site-directed mutagenesis, affinity labeling, steady-state kinetics, and 
crystal structures [4-6]. Evidence suggests that a double displacement acyl transfer mechanism 
obtains with an acyl-enzyme intermediate located on Ser241. The kinetics of turnover of 
substrate analogues suggests that acyl-enzyme formation is generally rate limiting under 
substrate saturation conditions [4]. The catalytic triad of FAAH is composed of Ser241-Ser217-
Lys142. The proposed mechanism involves the Lys142 amine, initially in the deprotonated state, 
functioning as a base to activate the nucleophilic Ser241, and as an acid to facilitate the 
protonation of the substrate leaving group. Both functions were proposed to be achieved via the 
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bridging residue Ser217. The latter intervention was thought to explain the unusual ability of 
FAAH to hydrolyze amides and esters at equivalent rates. The AS enzymes also appear to have 
active site and mechanistic similarities to other serine/amine enzymes, the β-lactam-recognizing 
enzymes and the N-terminal nucleophile (Ntn) amidohydrolases, probably as a result of 
convergent evolution [7,8]. 
In previous studies, MAH from Pseudomonas putida has been cloned, expressed in E. 
coli and characterized [1]. The catalytic triad of MAH is composed of Ser204, Ser180, and 
Lys100. Mutation of the catalytic residues resulted in total loss of activity for S204A and K100A 
and a 4200-fold decrease in the kcat/Km value for S180A [9]. Both (R)- and (S)-mandelamide are 
excellent substrates for MAH, while the enzyme can hydrolyze phenylacetamide with even 
higher catalytic efficiency. Kinetic data with alternative substrates indicates that the active site is 
sterically hindered, and the enzyme can tolerate very little substitution on the amide nitrogen. 
Similar to FAAH, MAH has the uncommon ability to hydrolyze esters and amides at similar 
rates. Here, we report the results of our studies with some new MAH substrates. We also 
interpret the substrate specificity structurally and examine the reactivity of MAH with some 
recently studied β-lactamase inhibitors.  
2. Materials and Methods
2.1 Materials  
Site-directed mutagenesis The MAH variants, F150L, F433A and F433L were prepared using 
PfuUltra HF DNA polymerase (Agilent) and the QuikChange site-directed mutagenesis protocol 
(Stratagene) with pET17MAH-His [1] as the template. The forward primers used for the 
mutagenesis are shown below with the mutated codon underlined and the lowercase letters 
indicating base change from the wt, 
F150L: 5′- CATGAGCTAGCGcTTGGgACCTCGGGC-3′ 
F433A: 5′- CCAGTTTCGAGGCCgcCGCtCGCATGATTCG-3′ 
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F433L: 5′- CCAGTTTCGAGGCCTTgGCACGCATGATTCG-3′ 
The primers also introduced AvaII (F150L), BsrB1(F433A) and StyI (F433L) sites which were 
used for restriction analysis in initial screening for mutations. The fidelity of the PCR 
amplification and the presence of the desired mutations were verified by sequencing (University 
of Michigan Sequencing Core). 
Protein expression and purification Wild-type and variant MAH were expressed with a C-
terminal 6x his-tag using the previously described methods [1,9]. Following purification the 
enzyme was kept at -20°C in a storage buffer containing 100 mM potassium phosphate buffer, 
pH 7.8, containing 1 mM EDTA. Enzyme concentrations were determined by UV absorption 
using an ε278 of 28,800 M-1cm-1 [9]. 
Phenylacetamide (3) (TCI), 4-nitrophenyl acetate (8) (Sigma-Aldrich), 4-nitrophenyl n-
butyrate (12) (Santa Cruz Biotechnology), 4-nitroacetanilide (10) (Acros), N-
benzyloxycarbonylglycinamide (20) (Chem Impex), and phenyl carbamate (21) (Sigma-Aldrich), 
and methyl mandelate (7) (Sigma) were obtained from commercial sources and used as supplied. 
R-Mandelamide was prepared as previously described [1]. Methyl 4-nitrophenylcarbonate (11) 
was prepared from reaction of 4-nitrophenyl chloroformate with methanol in the presence of 
triethylamine and recrystallized from an ethyl acetate/hexane mixture (7:3). Ethyl 4-nitrophenyl 
carbonate (13) was prepared from reaction of 4-nitrophenol with ethyl choroformate in the 
presence of aqueous sodium hydroxide and recrystallized from ethanol [10]. Methyl (5) and ethyl 
(6) 4-nitrophenylacetate were obtained by reaction of 4-nitrophenylacetic acid (Acros) with 
methyl and ethyl chloroformate, respectively, and the products recrystallized from 2-propanol. 4-
Nitrophenylacetamide (4) was obtained by ammonolysis of the ethyl ester in 30% aqueous NH3 
at 100°C. On cooling of the reaction mixture, pure crystals of 4 precipitated. Compound 16 was 
previously prepared in this laboratory [11,12]. The carbamates 16 and 19 were obtained by 
reaction of the corresponding hydroxamic acids with trimethylsilylisocyanate (Acros) and 
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purified by recrystallization from aqueous ethanol. Phenylmethylboronic acid was prepared in 
situ by hydrolysis of the pinacol ester (AlfaAesar). 
2.2 Methods   
All kinetics measurements with MAH were carried out at 25°C in 0.1 M phosphate buffer 
containing 1 mM EDTA at pH 7.8. The hydrolysis, ammonolysis and methanolysis of the amide 
4 and the ester 5 were monitored spectrophotometrically at 310 nm (Δε = 2140 M-1 cm-1) and 
320 nm (Δε = 1600 M-1 cm-1), respectively. DMSO (5 %) was included to facilitate dissolution of 
these substrates and MAH concentrations were 0.014 µM and 0.047 µM in studies of 4 and 5, 
repectively. Initial rates of MAH-catalyzed reactions were fitted to the Michaelis-Menten 
equation by a non-linear least squares method (Kaleidograph). Steady-state parameters for the 
MAH variants were obtained using S-mandelamide as substrate under the conditions described 
above. 
      Ammonium chloride and methanol inhibited the reaction of MAH with 4 (200 µM and 800 
µM) and 5 (1.0 mM), respectively. Under these substrate saturation conditions, the steady state 
equation for Scheme 3 yields equation 1, where v and v0 are the initial rates in  
v0/v = (1 + [XH]/Ki)-1                            (1) 
the presence and absence of the nucleophile XH, respectively, and the apparent inhibition 
constant Ki = (k2 + k3)/k-2. Thus values of Ki for ammonium and methanol were obtained for 4 
and 5, respectively. Initial rates of hydrolysis of 4 in the presence of several concentrations of 
phenylmethyl boronic acid were also obtained. These data were treated by assuming the boronic 
acid was a competitive inhibitor. 
The temperature effect on the hydrolysis of R-mandelamide was measured using the 
coupled enzyme assay for ammonia [1,9] in 100 mM phosphate buffer at pH 7.8 and containing 
1 mM EDTA. The assay mixture comprised the substrate, mandelamide, (10 - 200 µM), 250 µM 
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NADH, 800 µM α-ketoglutarate (Sigma), 15 U/mL glutamate dehydrogenase (Sigma), and 
MAH (0.14 – 0.91 µM).  
The temperature effect on the hydrolysis of methyl mandelate was measured using a pH-
stat assay [1] with an end point of pH 8.5. The assay mixture comprised the substrate methyl 
mandelate (100 – 800 µM), 1 mg/ml BSA, and MAH (9.1 – 36.5 µM). The reaction mixture was 
titrated with 5 mM sodium hydroxide solution. 
The hydrolysis of p-nitrophenyl acetate (8) was also studied spectrophotometrically. In a 
typical reaction, 5-20 µL of 8 in DMSO was added to phosphate buffer (50 mM, 1.0 mL) at pH 
7.8. To maintain substrate solubility, DMSO was included to a final concentration of 5% (v/v). 
The reaction mixture then remained transparent during the course of the measurements. After the 
reaction solution had reached thermal equilibrium, an aliquot of enzyme stock was added to 
initiate the reaction. The hydrolysis was followed spectrophotometrically by monitoring the 
absorbance increase at 400 nm due to production of p-nitrophenolate. A molar extinction 
coefficient of 18300 M-1cm-1 for p-nitrophenolate and a pKa of 7.1 for p-nitrophenol were 
assumed for calculation of the rates of hydrolysis. The observed absorbance increase at 400 nm 
represents a sum of two reactions, enzymatic hydrolysis and nonenzymatic hydrolysis of 8. 
Therefore, corrections were made for the nonenzymatic hydrolysis by subtracting the rate 
observed in the absence of enzyme from that in the presence of enzyme under the same 
conditions. For the determination of kcat and Km parameters, initial rate measurements were 
performed under steady state conditions with the substrate concentration in the range of 0.1 to 
1.6 mM and the enzyme at 45 nM. The hydrolysis of 9 and 11 - 13 were studied in a similar 
fashion.  
Compounds 16, 17, 19 - 21 were first tested as substrates of MAH from 
spectrophotometric progress curves of their reactions in the presence of the enzyme. They were 
also tested as inactivators of the enzyme by incubating each one of them separately with the 
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enzyme and assaying aliquots of the reaction mixtures against 500 µM 4-nitrophenyl acetate at 
400 nm. The initial rates, proportional to enzyme activity, were plotted against time to obtain 
progress curves that were fit to Scheme 1 (where Q is the hydrolysis product of inhibitor I) by 
the Dynafit program [13] to obtain the rate constants of inactivation. For compound 17, the 
inhibition of the enzyme was observed in total progress curves of the hydrolysis of 4 in the 
presence of the inhibitor (from adding the enzyme to a mixture of substrate and inhibitor). The 
resulting progress curves were fitted to Scheme 2 to obtain the kinetic parameters. The presence 
of MAH-catalyzed hydrolysis of 4, 16, and 19 was also confirmed by means of a well-
established ammonia assay [1,9].
Scheme 1 
Scheme 2 
Molecular modeling simulations were performed on a SGI workstation running 
the program Insight II, essentially as previously described [12]. The homology structure of MAH 
[9] was modified to obtain the adduct 14 with the active site Ser 204. The ligand was placed 
manually following the example of the crystal structure of FAAH covalently bound through its 
active site to a phosphonate transition state analogue (PDB ID 1MT5 [6]). The pH was set to 7.0 
where the side chain of Lys100 was cationic. The active site was hydrated with a 20 Å sphere of 
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water centered on Oγ of the nucleophilic serine 204. The model was then subjected to 1000 steps 
of steepest descent energy minimization, followed by 2000 steps of conjugate gradients.  
3. Results and Discussion
3.1 Substrate Specificity 
Previous studies of MAH have shown that R- (1) and S-mandelamide (2) are comparably 
efficient (kcat/Km) as substrates and that phenylacetamide (3), lacking an α-substituent, is even 
more efficient (Table 1) [1,9]. None of the previously described substrates, however, are suitable 
for a convenient direct spectrophotometric assay. The closest approximation to a direct assay is a 
coupled enzyme procedure using glutamate dehydrogenase to monitor ammonia released by 
MAH [9]. Thus, we prepared p-nitrophenylacetamide 4 and showed it to have 
spectrophotometric properties suitable for a direct assay (Figure 1). A 1H NMR experiment 
showed that 4 is a MAH substrate, yielding p-nitrophenylacetate. The ammonia assay also 
showed release of ammonia as a product. We therefore used 4 as a convenient assay substrate for 
further studies of the enzyme (see below), monitoring its hydrolysis catalyzed by MAH at 310 
nm (Δε = 2140 M-1cm-1). Thus, from initial rate measurements, the steady state parameters for 
turnover of 4 by MAH were determined (Table 1). The methyl (5) and ethyl (6) ester of p-
nitrophenylacetic acid were also prepared. 
CH CO2Me
7
CONH2
H
CONH2
OH
OHH
CONH2
H
H
CH2 COX
4 X = NH2
5 X = OMe
6 X = OEt
O2N
1(R) 2(S) 3
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Fig. 1. Absorption spectra of 4 before (¡) and after (¨) hydrolysis catalyzed by MAH 
The methyl ester 5 was a poorer substrate than 4 because of its ten-fold higher Km and the ethyl 
ester 6 was not a substrate of MAH at all. The latter results are in accord with previous 
observations with mandelate esters and N-alkyl phenylacetamides [9] which also suggested that 
extended leaving groups had difficulty, presumably steric, in accessing the active site. The 
chemically counterintuitive similar reactivity of amides and esters as substrates of MAH,  
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Table 1. 
Steady State Parameters for Hydrolysis of Substrates by MAH 
Substrate kcat (s-1) Km (µM) kcat/Km (µM-1 s-1) 
1a 82 7.0 11 
2a 150 20 8.3 
3a 46 0.9 51 
4 43 ± 3 36 ± 7 1.2 
5 44 ± 6 400 ± 100 0.11 
6b
7c                                                                      
-­‐ 
63	  
- 
170 
- 
0.37 
8 5.1 ± 0.5 2300 ± 300 2.2 x 10-3 
9d -­‐ - (4.9 ± 0.1) x 10-4 
11 0.52 ± 0.06 470 ± 110 1.1 x 10-3 
12 
13 
NDe
ND 
ND 
ND 
(1.2 ± 0.1) x 10-5
(1.7 ± 0.1) x 10-5
a. From reference 9.
b. No reaction observed.
c. From reference 1.
12	  
d. No sign of saturation observed at achievable concentrations (100 µM).
e. ND, not determined
observed here and previously [1,9], is found also in the homologous enzyme FAAH, discussed in 
the introduction, and led to the proposal of a novel mechanism involving a Ser Ser Lys triad [4].  
Evidence has been reported for a double displacement acyl transfer mechanism for 
FAAH with an acyl-enzyme intermediate located on Ser 241. Studies of the kinetics of turnover 
of substrate analogues suggested that acyl-enzyme formation was generally rate-limiting under 
substrate saturation conditions [4].  The identity of MAH as a serine hydrolase is supported by 
the effects of specific inhibitors. MAH, like FAAH, is inhibited for example by 
phenylmethylsulfonylfluoride and MAH also by the electrophilic ketone 3-phenyl-1,1,1-
trifluoro-2-propanone (Ki = 60 µM) [1]. We have now shown that MAH is strongly inhibited by 
phenylmethylboronic acid [Ka = (27 ± 4) nM]. This compound is likely to form a tetrahedral 
anionic complex with the active site serine, mimicking the deacylation transition state in turnover 
of phenylacetamide. Boronic acids are well known to form such complexes with serine 
hydrolases [14]. Thus, substrates most likely react with MAH to form, initially, a covalent acyl-
enzyme with the nucleophilic active site serine (Ser204). This mechanism is shown in Scheme 3 
where the acyl-enzyme intermediate is depicted as RCOOE. This representation indicates the 
presence of the acyl group of normal substrates in a specific binding site (see below).  
 A question that does arise, however, in comparison of the ester and amide substrates, is 
the nature of the reaction step defining kcat, acylation or deacylation of the active site serine of 
the enzyme (Scheme 3). Note that it is assumed in the derived equations that the second step is 
irreversible in the absence of added product and under initial rate conditions. It is also assumed 
that the reaction of the first step, substrate binding, is a fast pre-equilibrium, ie k-1, the rate 
constant for substrate dissociation is much greater than k2. This has also been assumed for FAAH 
[4]. Further, the kcat/Km values for compounds 3, 4, and 5 do not suggest that diffusion-controlled 
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association of enzyme and substrate is rate-limiting for 4 and 5. The coincidence of kcat values 
for the amide 4 and the ester 5 suggests that a common step, which would most likely be 
deacylation (k3), is rate-limiting. The latter conclusion would be unusual for AS enzymes [4] but 
there is no fundamental reason why acylation should rate-determining for all AS enzymes and 
substrates. This point is reiterated below for MAH and the substrates mandelamide and methyl 
mandelate. 
Scheme 3 
The values of kcat of mandelamide and methyl mandelate (7) are sufficiently different  
(Table 1) to preclude rate-determining deacylation at saturation for both ester and amide. Rate-
determining acylation in each case would remain possible. In order to try and resolve this issue, 
we decided to apply a perturbation method first described by Fitzpatrick [15]. Scheme 3 leads to 
the steady state equations shown in Scheme 3 it if it is assumed that substrate binding can be 
described as a fast equilibrium (Ks). 
If it is also assumed that the equilibrium constant Ks is less temperature sensitive than the 
rate constants k2 and k3, then, for a given substrate, the temperature dependence of kcat and 
kcat/Km should be very similar, reflecting k2, if acylation is rate-determining, and may be quite 
different if deacylation is rate-determining since the change in kcat will reflect the temperature 
dependence of k3 and kcat/Km that of k2. Data from temperature dependence studies of kcat and 
E-OH   +   RCOX E-OH.RCOX RCOO-E
  + XH
E-OH   +   RCO2-
H2O
k3
Ks
k2
k-2
kcat = k2k3/(k2 + k3)         Km = Ks[k3/(k2 + k3)]    kcat/Km = k2/Ks
Rate-determining acylation, k3 > k2
kcat = k2                         Km = Ks       kcat/Km = k2/Ks
Rate-determining deacylation, k2 > k3
kcat = k3                         Km = Ks(k3/k2)       kcat/Km = k2/Ks
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kcat/Km for 1 and 7 are shown in Figure 2 along with Ea values calculated from linear fits to the 
data. The Ea values for kcat and kcat/Km are very different for 1 and 7 and thus, from the rationale 
above, deacylation is likely to be rate determining. Conversely, for 7 the Ea values for kcat and 
kcat/Km are the same within experimental uncertainty and thus acylation is likely to be rate 
determining for this substrate. It follows in the latter case that Km (= Ks) has very little 
temperature dependence, as required by the theory. 
This result, rate-determining acylation for the ester and deacylation for the 
corresponding amide is chemically rather counter-intuitive because the amide is much less 
hydrolytically reactive than the ester. For catalysis by MAH, however, the result is reasonable 
since the restricted leaving group site, discussed above, may restrict enzyme acylation by the 
methyl ester which bears a larger leaving group than the amide. This factor is probably also 
involved in rationalization of the relative kcat/Km values of 4 and 5.  
As suggested by Scheme 3, hydrolysis of 4 should be impeded by addition of the 
protonated leaving group (XH), NH3 in this case. Ammonium chloride was indeed found to be 
inhibitory to hydrolysis of saturating 4 with an apparent Ki value of (0.6 ± 0.1) M. If it is 
assumed that the actual inhibitor is ammonia (Scheme 3), the corrected (assuming the pKa of 
ammonium to be 9.25) Ki value is 0.0355 M. Similarly, the hydrolysis of 5 was inhibited by 
methanol: Ki = (0.30 ± 0.05) M. Thus, as required by Scheme 3, formation of the acyl-enzyme is 
reversible. Methylamine (to 2.0 M) had no effect on the rate of reaction of either 4 or 5, as 
expected since N-methyl-phenylacetamide is a much poorer substrate (kcat/Km = 7 x 102 M-1 s-1 
[1]) than 3.  
NO2CH3COO CH3COO
8 9
NO2CH3CONH
10
NO2CH3OCOO
11
NO2CH3CH2CH2COO
12
NO2CH3CH2OCOO
13
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Fig. 2 Temperature dependence of  kcat (l) and kcat/Km (¡) values for hydrolysis of 
mandelamide and methyl mandelate catalyzed by MAH. 
We have shown that MAH also catalyzes the hydrolysis of the non-specific substrate p-
nitrophenyl acetate 8 [kcat = (5.1 ± 0.5) s-1, Km = (2.3 ± 0.3) mM, kcat/Km = 2.2 x 103 M-1 s-1]. It 
seems unlikely that the leaving group of 8, p-nitrophenolate, could fit into the leaving group site 
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of MAH. As mentioned above, anything larger than a methoxy group does not bind there and 
react. In particular, p-nitrophenyl phenylacetate is not a substrate [1]. We suggest, therefore, that 
8 binds and reacts in the MAH active site in reverse fashion. The p-nitrophenyl group would 
occupy the normal acyl site (which is quite specific for aromatic groups [1,9]) and the acetyl 
group would occupy the normal leaving group site. Thus there would be formed a “flipped” or 
inverse acyl-enzyme E-OCOCH3 (Scheme 4), where this representation reflects occupancy by 
the acetyl group of the normal leaving group site. 
Scheme 4 
The mechanism of turnover of a normal substrate, phenylacetamide, is shown for comparison. 
The catalytic acids and bases also involved in catalysis have been omitted for simplicity. Unlike 
the normal ammonia leaving group, p-nitrophenolate would not require a general acid catalyst to 
leave and thus the inverse binding mode can be productive. Phenyl acetate (9) is also a substrate, 
not greatly poorer than p-nitrophenyl acetate (Table 1), suggesting that nucleophilic attack by 
serine rather than departure of phenolate may be the rate-determining step in acylation. The 
analogous amide 10, with a much poorer leaving group, is not, however, a perceptible substrate. 
The carbonate 11, with an acyl group still small enough to fit into the leaving group site, is also a 
substrate, although somewhat poorer than 8 (Table 1). The rate of hydrolysis of 11 (1.0 mM) 
OO2N C
O
CH3
E-OH
EO C
O
CH3
H2O
E-OH   + CH3 CO2-
CH2 C
O
NH2
E-OH
CH2 C
O
OE
+ NH3
H2O
E-OH   + CH2 CO2-
+ OHO2N
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catalyzed by MAH is not affected by addition of ammonium chloride  (to 0.5 M). This suggests 
that acylation of the enzyme by 11, presumably to form EOCOOCH3, is rate determining. The 
same is probably true for 8 also but the ammonia experiment could not be reliably done in this 
case because of the higher background rate of hydrolysis and aminolysis of 8. We also note that 
the abnormal acyl-enzymes EO-COCH3 and EO-COOCH3 may, in principle, rearrange to the 
normal conformation CH3CO-OE and CH3OCO-OE prior to hydrolysis. In this case, the kinetics 
and/or thermodynamics of the rearrangement may influence k3 values. 
Finally, we examined the MAH-catalyzed hydrolysis of 4-nitrophenyl n-butyrate (12) and 
ethyl 4-nitrophenyl carbonate (13), which are analogous to 8 and 11, respectively, but with 
longer acyl groups. As expected from the above discussion, these compounds were very poor 
MAH substrates (Table 1) and thus, together with previous results described above, provide an 
accurate limit to the size of the MAH leaving group pocket (for normal substrates) 
It was reported earlier that the G202A mutation of MAH strongly decreased by a factor 
of 20- to 50-fold the reactivity (kcat/Km) of (acyl)aromatic substrates but that of aliphatic 
substrates (intrinsically weaker) increased [9]. This mutation was now found to significantly 
reduce kcat/Km of 8 by a factor of 21, a result that suggests the aromatic ring of 8 during acylation 
may be located at the same site as that from 3. This interpretation supports the proposal of 
acylation of MAH by 8 with the latter in the reverse to normal orientation. 
These experiments with 8 and 11 appear to open up a new avenue of reactivity of the 
MAH active site, which is hampered by the small leaving group cavity. This should be relevant 
to the design and reactivity of covalent inactivators of MAH (see below). 
3.2 Structural Interpretation 
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Although a crystal structure of MAH is not available at this time, a homology model 
based on the crystal structure of other amidase signature enzymes, particularly FAAH, has been 
constructed [9]. We have used this model to interpret the substrate specificity of MAH. We 
constructed a model of the tetrahedral intermediate 14 generated from attack of MAH on the  
very good substrate phenylacetamide. The ligand was placed manually following the example of 
the crystal structure of FAAH covalently bound through its active site to a phosphonate transition 
state analogue (PDB ID 1MT5 [6]). After energy minimization, the structure shown in Figure 3A 
was obtained. This shows the substrate covalently bound to Ser204, the oxyanion O- hydrogen-
bonded into the oxyanion hole (NH groups of Thr201 and Gly202 and, perhaps, the side chain 
hydroxyl of Thr201), and the leaving group nitrogen (neutral) hydrogen bonded to the hydroxyl 
of Ser180, which is accompanied by Lys 100. The side chain oxygen atom of Ser 204 is also 
within hydrogen-bonding distance of Ser180 Oγ. These placements are analogous to those in the 
FAAH phosphonate reference structure and can be interpreted in terms of the proposed 
mechanism of catalysis [4]. Two new points can be made relevant to the substrate specificity of 
MAH. First, the phenyl group of phenylacetamide is neatly placed in a hydrophobic cleft, 
stacked between the aromatic rings of Phe150 and Phe433. There is room for substitution of 
either an R or S hydroxyl group on the benzyl methylene to generate a mandelamide 
intermediate. The model also indicates why benzamide is not a MAH substrate [1]. In this case, 
the phenyl ring of benzamide would be directed, not between the phenylalanine rings, but rather 
directly at the phenyl ring of Phe433, leading to unfavorable steric interactions. Aliphatic amides 
OSer(E)
C
H2 NH2
O-
14
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of appropriate alkyl length, unless with bulky branched side chains [9], could also be seen as 
accommodating to the model.  
Table 2 lists the steady state parameters for single site variants of MAH where Phe433 
and Phe150 have been replaced. Mutation of Phe433, particularly to an aliphatic residue, has a 
large negative effect on the activity of the enzyme (kcat/Km) but mutation of Phe150 seems to 
have less effect. Changes occur in both kcat and Km, all unfavorable except for Km for the F150W 
variant which becomes smaller. The model, Figure 3A, shows the phenyl group derived from 
phenylacetamide closely π-stacked onto that of Phe433 while that of Phe150 seems to interact 
less closely with the substrate. The change of Phe150 to the larger Trp does seem to improve 
substrate binding. Thus, the results of these mutations therefore do support the model shown in 
Figure 3A. 
Table 2. Steady state parameters for wild type MAH and certain variants (see text). The 
substrate was S-mandelamide in all cases. 
Enzyme kcat (s-1) Km (µM) kcat/Km (M-1s-1) 
WT 150 ± 4 18 ± 2 8.47 x 106
F433W 90 ± 2 43 ± 1 2.32 x 106
F433L 105 ± 1 135 ± 5 7.78 x 105 
F433A 20 ± 1 1530 ± 30 1.29 x 104 
F150W 43 ± 1 9 ± 1 4.63 x 106
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The position of the phenyl group of phenylacetamide bound to MAH can be compared 
with the position of the aliphatic fatty acid side chain of a FAAH substrate. Figure 3B shows an 
overlap of the model of Figure 3A with the FAAH-phosphonate crystal structure mentioned 
above. It can be seen that just as the phenyl group of the phenylacetamide complex with MAH 
sits between two phenylalanine phenyl rings, the aliphatic chain of the FAAH substrate, on 
leaving the reaction center, lies between the hydrophobic side chains of Leu192 and Ile491 [6]. 
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Fig 3. (A) A model of the deacylation tetrahedral intermediate derived from reaction of MAH 
with phenylacetamide (3) (see text). (B) Superimposition of the MAH model from above (atomic 
colors) and the relevant part of the crystal structure of FAAH modified by a phosphonate 
transition state analogue inhibitor (PDB ID 1MT5, purple). This diagram was achieved by 
superimposition of  the α-C of the catalytic active site residues (for MAH, these are Lys100, 
Ser180, Thr201 and Ser204). 
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Fig 4. Extended view of the superimposition of MAH (atomic colors) and FAAH (purple) shown 
in Figure 2B, showing the loops adjacent to the active site in the vicinity of a leaving group 
during catalysis. The loops shown comprise Val226 – Pro234 (MAH) and Ser262 – Thr274 
(FAAH). 
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A second important aspect of MAH specificity is its strong preference for small leaving 
groups, with no more than two heavy atoms apparently permitted (see discussion above). MAH 
differs from FAAH in this respect since latter enzyme can accomodate larger substitutions in the 
leaving groups of substrates, e.g. anandamide [16]. The greater space in the leaving group 
position available to FAAH ligands has been extensively taken advantage of in the design of 
FAAH inhibitors such as α-ketoheterocycles, carbamates and ureas [17]. One protein structural 
difference that may lead to this difference is seen in Figure 4 where relevant portions of MAH 
and FAAH are overlaid. A broad loop in FAAH adjacent to the leaving group position (Ser262-
Thr276) is replaced in MAH by a shorter one (Val226-Pro234). The loop in MAH seems well 
placed to unfavorably interact sterically with large leaving groups. Note that these loops are 
internal to the protein (the active site is buried in the protein) and not expected to be flexible [the 
loop in MAH did not flex significantly during a short molecular dynamic run (100 ps)]. 
3.3 Inhibition by O-Acyl Hydroxamic Acids 
O-Acyl hydroxamic acids of general structure 15 are mechanistically interesting 
inactivators of serine β-lactamases. They act by crosslinking the active site between the 
nucleophilic serine and an adjacent conserved lysine [11]. The β-lactamases have active site 
similarity to another family of serine/lysine amidohydrolases, the N-terminal nucleophile 
peptidases, which are also inhibited by 15 in a manner that crosslinks the active site between 
hydroxyl and amine groups of the N-terminal threonine/serine [8]. Since there are also congruent 
similarities with the active sites of amidase signature enzymes [7], we assessed the reactivity of 
one of these enzymes, MAH, with several O-acyl hydroxamic acids, all distinguished from 15 by 
their small leaving groups, appropriate for MAH . Compound 16, although a primary amide, was 
neither a MAH substrate nor an inhibitor. The polar hydroxamate moiety in this case is 
apparently unable to productively engage the MAH active site. The chemically more reactive 
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methyl ester analogue 17, however, did however react slowly to form a transient intermediate. 
Figure 5 shows the results of an experiment where turnover of the substrate 4 was monitored in 
the presence of 17 after addition of the enzyme to a mixture of substrate and inhibitor. The figure 
shows a burst of product formation from the substrate and then a slowing of turnover, 
presumably because of reaction of the enzyme with 17 to generate a transiently stable complex 
that then slowly breaks down to reform active enzyme. An alternative addition experiment, 
whereby substrate was added to a mixture of enzyme and 17, incubated for 5000 s, yielded a 
largely inactive enzyme that regained activity at a rate consonant with Figure 5. The data of 
Figure 5 were fitted to Scheme 2 by Dynafit [13] to obtain k1 and k2 values (Table 3). It is likely 
that 17 yields the acyl-enzyme 18 as a slowly hydrolyzing intermediate since the alternative acyl-
enzyme EOCOOCH3 hydrolyzes more rapidly (See discussion of 11 above). The compound 17 is 
therefore quite an effective inhibitor of MAH with an effective Ki (= Km = k2/k1) of 25 nM. 
Unlike 16, the benzyloxy analogue 19 reacts with MAH much like 17, but acylates the enzyme 
much more slowly. Presumably, the more flexible side chain of 19 allows it weakly productive 
access to the active site, c.f. 16.  
C
O
RO NHO C OAr
O
15
C
O
NHO C NH2
O
16
C
O
NHO C OMe
O
17
C
O
NHO C OE
O
18
C
O
O NHO C NH2
O
19
CH2 C
O
O NHCH2
20
CH2 C
O
NH2
21
O C
O
NH2
26	  
Fig 5. Turnover of 4 (100 µM) by MAH (14 nM) in the absence (¡) and in the presence (¨) of 
17 (25 µM). The solid lines represent the fit of the data to Scheme 2. 
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Table 3. 
 Kinetics of Reaction of MAH with O-Acyl Hydroxamates 
Compound k0 x 104 (s-1) k1 (M-1s-1) k2 x 105 (s-1) Km ( = k2/k1) (µM) 
16 7.0 - - -­‐ a 
17 4.8 770 ± 20 1.9 ± 0.1 0.025 
19 ND 0.35 ± 0.06 ≤ 50 ≤ 1400 
a No reaction with the enzyme observed 
The question arises, however, from these results as to the reason behind the weak 
interactions of the amides 16 and 19 with the MAH active site. Does it derive from the fact that 
they are carbamates or is from the overall polarity of the side chains. These issues were 
examined in the following two experiments. First, the ability of N-benzyloxycarbonyl- 
glycinamide 20 (compare its structure with that of 19) to act as a substrate was tested. A 1H 
NMR experiment showed no hydrolysis of 20 (2 mM) by MAH (0.28 µM) in 3 days. Certainly, 
therefore, the extended polar side chain is a problem at the MAH active site. On the other hand, 
the presence of a carbamate also seems to present problems. Phenyl carbamate 21 (compare its 
structure with that of 3) was also not a MAH substrate, either by spectrophotometry or ammonia 
assay. The presence of the carbamate oxygen rather than a methylene group reduces kcat/Km by at 
least five orders of magnitude. Clearly the carbamate is severely impeding attack by MAH, most 
likely because of the greater rigidity of 21 than 3. The carbamate moiety is planar with a 
rotational barrier of around 12 kcal/mole for rotation about the O-(C=O) bond [18]. Molecular 
mechanics models suggest a rotation of 90 -100o around this bond, thus costing close to the 
maximal energy, would be needed to adjust phenyl carbamate to the ground state 
phenylacetamide geometry. The barrier for rotation about the C-(C=O) bond of phenylacetamide 
is much lower. It may be then that the difficulty of achieving a reactive conformation in the 
active site is responsible for its lack of reactivity. Thus, both the polar side chain and the 
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presence of the carbamate moiety appear to contribute to the slow reaction of O-carbamoyl 
hydroxamates with MAH. These compounds do not irreversibly inhibit MAH by cross-linking of 
the active site, as happens with β-lactamases and N-terminal nucleophile proteases, probably 
because of the absence in MAH (and AS enzymes in general) of an amine directly adjacent to the 
nucleophilic serine hydroxyl group.  
4. Conclusions
We have shown that p-nitrophenylacetamide is a convenient direct reading chromogenic 
substrate of MAH, suitable for analytical purposes. Comparison of its reactivity with MAH with 
that of the corresponding methyl ester confirms the comparable rates of reaction of MAH with 
amides and esters, similar to those previously observed with FAAH, and presumably for the 
same mechanistic reasons. The lack of reactivity of MAH with the corresponding ethyl ester 
confirms the limited size of the MAH leaving group site. Phenylmethylboronic acid, presumably 
a transition state analogue precursor, is a potent inhibitor of MAH. The reactivity of MAH with 
4-nitrophenyl acetate (8) and 4-nitrophenyl methyl carbonate (11) suggest the formation of 
“inverse” acyl enzyme species where the small acyl group occupies the normal leaving group 
site. We have recently found that the reactivity of an N-terminal nucleophile amidohydrolase, 
penicillin acylase, with O-acyl hydroxamates also provides evidence for “inverted” acyl-enzyme 
forms [19]. 
There is evidence that either enzyme acylation or deacylation may be rate-determining 
under kcat conditions depending on the substrate. Acylation is probably rate determining for 11 
and methyl mandelate 7 and likely for 8, while deacylation is more likely to be rate-determining 
for the amide 4, the ester 5 and R-mandelamide 1. 
We have interpreted the substrate specificity of MAH in terms of its active site structure. 
The aryl specificity of the acyl group of MAH substrates arises form a specific aryl binding site 
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between two phenylalanine side chains (Phe150 and Phe433). The small leaving group site of 
MAH is dictated by a rigid loop of the protein backbone closely adjacent to the active site 
(Val226 – Pro234). These elements of specificity have been compared to those of FAAH, whose 
substrates have an aliphatic acyl group and the possibility of larger leaving groups. 
Inactivation of MAH by O-acyl hydroxamates was slow because of the inflexible and 
polar hydroxamate moiety. One such compound, O-methoxycarbonylbenzohydroxamate (16), 
however, was a quite effective transient inactivator of MAH (Ki = 25 nM, koff = 1.9 x 10-5 s-1). 
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